Durham, North Carolina-based IQVIA Holdings Inc. (IQV) provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas and internationally. Valued at a market cap of $34.6 billion, the company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
IQV is expected to release its Q2 2026 earnings soon. Ahead of the event, analysts expect the company’s EPS to be $2.74 on a diluted basis, up 8.3% from $2.53 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.